Metastatic small-cell carcinoma of rectum responding dramatically to combination chemotherapy

Am J Clin Oncol. 1998 Feb;21(1):75-6. doi: 10.1097/00000421-199802000-00017.

Abstract

Small-cell carcinoma of the rectum, is very rare with a dismal prognosis that follows a more aggressive course than the pure exocrine counterparts. As a result, survival is usually very poor. A male patient with metastatic disease is presented in this report. After receiving six cycles of combination chemotherapy regimen consisting of cyclophosphamide, adriamycin, and etoposide, he is in complete remission for >3 years. Although it is a single case, it shows that combination chemotherapy may achieve an excellent result even in a metastatic case of small-cell carcinoma of the rectum.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Small Cell / secondary*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Humans
  • Male
  • Rectal Neoplasms / drug therapy*
  • Remission Induction

Substances

  • Etoposide
  • Doxorubicin
  • Cyclophosphamide